Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2024 Oct 28;53(3):535–546. doi: 10.1002/jcu.23864

Klippel‐Trénaunay‐Weber Syndrome: Prenatal Diagnosis and Review of the Literature

Giuliana Orlandi 1, Laura Sarno 1,, Antonio Angelino 2, Mariarosaria Motta 2, Raffaella Di Girolamo 2, Luigi Carbone 3, Marika Rovetto 2, Laura Letizia Mazzarelli 3, Gabriella Sglavo 3, Francesco D' Antonio 4, Ilenia Mappa 4, Daniele Di Mascio 5, Giuseppe Rizzo 5, Giuseppe Maria Maruotti 2
PMCID: PMC11907225  PMID: 39467282

ABSTRACT

Klippel‐Trénaunay‐Weber syndrome (KTW) is a rare congenital disease, representing a challenge in prenatal diagnosis due to overlapping characteristics with other syndromes and no specific genetic markers known to date. We have collected all the cases present in the literature on the prenatal diagnosis of KTW, emphasizing common ultrasound findings that can guide the clinician and genetics to the prenatal counseling. Thus, we collected all the information about the postnatal prognosis and the necessity for treatment. Our review of 44 cases highlights the typical common features: hemihypertrophy, predominantly affecting the right leg, with cystic lesions extending to the trunk or upper limbs and rare internal organ involvement. Prenatal complications, including hydrops and polyhydramnios, emphasize the need for a careful ultrasound follow‐up. Despite no identified genetic mutation, genetic counseling and invasive testing are recommended. Mortality rate due to a severe complication known as Kasabach‐Merritt syndrome, underlines the importance of early diagnosis and accurate management strategies. Prenatal diagnosis of KTW, guided by ultrasound findings and genetic counseling, could help with informed decision‐making and optimal care planning.

Keywords: hemihypertrophy, Klippel‐Trénaunay, overgrowth syndrome, prenatal diagnosis


This meta‐analysis demonstrates the high diagnostic accuracy of SZ‐CEUS for differentiating between malignant and benign focal liver lesions, as well as for HCC from non‐HCC lesions. The study shows better performance for smaller lesions and those with a higher proportion of malignancy.

graphic file with name JCU-53-535-g002.jpg

1. Introduction

The Klippel‐Trénaunay‐Weber syndrome (KTW), also known as “hemangiectatic hypertrophy syndrome” and “angio‐osteohypertrophy syndrome”, is a rare and congenital disease, first described by Maurice Klippel and Paul Trénaunay in 1900. The incidence has been estimated at around 2–5:100000 [1]. This syndrome has a sporadic incidence without any racial or sex predilection [2] and it is characterized by typical features: port wine stains/capillary, venous malformation or varicosities, and limb hypertrophy [3].

Prenatal diagnosis can be challenging, due to the overlapping with other overgrowth syndromes; thus, a specific related genetic mutation has not been recognized, leading to a difficult genetic diagnosis [4].

Prenatal diagnosis can help the couple whether to continue the pregnancy and to program the birth and the successive follow‐up and surgical planning.

We report a review of the literature of prenatally diagnosed cases, to describe the most common ultrasound features, the risk of heart failure developing in utero, polyhydramnios and hydrops, and postnatal prognosis.

2. Material and Methods

The literature search was conducted using Web of Science, Scopus, MEDLINE, and Embase, as electronic databases from the inception of each database to February 2024, utilizing combinations of the relevant medical subject heading (MeSH) terms, key words, and word variants for: “Klippel–Trénaunay–Weber syndrome” and “prenatal diagnosis”. A review of articles also included the abstracts of all references retrieved from the search.

Inclusion criteria were prenatal diagnosis assessment of KTW cases. Only studies reporting the KTW description and the ultrasound features were eligible for the review. Two authors (GO and AA) reviewed all abstracts independently. Agreement regarding potential relevance was reached by consensus with authors. Full‐text copies of those articles were obtained, and the same two reviewers independently extracted relevant data. Inconsistencies were discussed and consensus was reached, or the dispute was resolved by discussion with the senior author (GMM). PRISMA guidelines were followed. Only full‐text and English‐written articles were considered eligible for inclusion.

3. Results

Thirty‐six articles of case reports of prenatal diagnosis of KTW syndrome were found, including 44 cases, eligible for inclusion in our review (Table 1—Figure 1) [4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39].

TABLE 1.

Case reports of prenatal diagnosis of KTW.

Paper number Year Author Age G.A. at diagnosis Fetal anemia Limb involvement Trunk involvement Neck/head involvement Upper arms Extension Internal organs involvement Histologic diagnosis of the lesions
1 2023 GICA N. NN 26 No Left Yes No No Left buttock, pelvic area Port wein stain
2 2023 SINGH (case 1) 26 39 No Right Yes No No Glutall region No Low‐flow vascular malformation
SINGH (case 2) 25 18 Yes Right No No No No No Hemang‐ioma
SINGH (case 3) 33 23 No Left No No No No No NN
SINGH (case 4) 36 31 Yes Right No No No No No NN
3 2006 PENG (case 1) 22 28 No Left Yes No No Left back Port wein stain
PENG (case 2) 26 35 Yes Right No No No No Hemangioma
4 2013 CAKIROGLU 27 26 No Right Yes No No Scrotum, lower trunk Port wein stain
5 2021 HOU‐QING 25 18 No Right No No No No NN
6 2014 TANAKA 27 25 Yes Both legs Yes No No Chest, retroperitoneum Hemangioma, port wein stains
7 2020 DONGMEI 26 17 No Left No No No No Port wein stains
8 1998 PALADINI (case1) 21 17 No Right Yes No No Right iliac fossa Hemangioma of bowel liver, kidneys Hemangioma
PALADINI (case2) 23 18 Yes Right Yes No Yes abdomen, trunk (axillar mass) NN
9 1992 HEYDANUS 34 20 No Right Yes No No Right buttock, hip Hemangioma
10 2006 Chih‐Ping 35 22 No Right Yes No No Abdomen Hemangioma
11 1994 Jorgenson 30 19 No Left foot No No No No Hepatic hemangioma Hemangioma
12 2000 Goncalves 28 30 No Right Yes No No Right buttock, flank Port wein stains
13 2003 Sahinoglu 18 24 No Left No No No No Hemangioma
14 1991 Drose 24 29 No Right No No No No NN
15 1983 Warhit 30 20 No Left Yes No No Buttock, foot Varicous, hemangioma
16 2003 Assimakopoulos 36 22 No Left Yes No No Abdome, thorax, gluteus Bowel hemangioma Port wein stains
17 2009 Coombs 32 24 No Both legs Yes No No Retroperitoneum, pelvis Bilaral agenesia of part femoral vein, popliteal veins
18 1981 Hatjis 34 30 No Left Yes No No Thorax, abdomen Cutaneous hemangioma
19 1993 Hayashi 26 19 No NN Yes No No Buttock, lower abdomen No Hemangiolinfangioma
20 2019 Ivanitskaya (case1) 21 20 No Left Yes No Yes Thorax, dorsum, abdomen, both buttock, axillary region Right lung solid mass 15×12×12 mm, solid mass abdomen 6 mm Port wine stains
Ivanitskaya (case 2) 36 32 No Left Yes No No Lumbar region, buttcock Port wine stains
Ivanitskaya (case 3) 31 24 No Left Yes No Yes Left buttock, low abdomen Port wine stains—vein varicose
Ivanitskaya (case 4) 31 29 No Right arm Yes No Yes Right thorax, right arm mixed cystic and solid structure, right shoulder and forearm Right lung solid mass NN
21 1986 Lewis 25 22 No Both legs Yes No Yes Abdomen, chest wall, left forearm, buttocks thighs, retroperitoneum Azygos vein, pericardium Hemangiomas
22 1991 Meholic 28 23 No Left arm Yes No Yes Chest wall, lower abdomen, pelvis Hemangiomas
23 1994 Meizner 41 15 No Right Yes No No Sacro coccigeal region, left chest wall No Hemangiomas, varicosities of abdominal wall
24 1988 Mor 31 30 Yes Right No No No No No Port wine stains
25 1984 Seoud 36 17 No NN Yes Yes No Upper abdomen and neck No Hemangiomas
26 1988 Shalev 28 33 No Right Yes No Yes Abdomen, left arm No Hemangiomas
27 1993 Yancey 22 26 No Left Yes Yes No Cystic and solid, multiloculated anterior neck mass No Hemangiomas
28 1994 Yancowitz 27 17 No Right Yes Yes Yes Eedema of rigth body No NN
29 2001 Zoppi 28 28 Yes Right Yes No No Hypoechoic and anechoic areas, right abdomen, sacral and perineal area Bowel, right kidney involved Hemangiomas, port wine stains
30 1998 Shih 32 15 No Left No No No No Hemangiomas
31 1999 Christenson 34 34 No Right Yes No No Retroperitoneum Port wein stains
32 1999 Roberts 26 19 No Left Yes No Yes chest, right arm Hemangiomas
33 2001 Martin 21 20 No Left Yes Yes No Torax, neck, scalp, retroperitoneum Hemangiomas
34 2000 Meja NN 20 No Right Yes No No No Intestine NN
35 2009 Volkow NN 22 No Arms Yes No Yes No No NN
36 2011 Al Asali NN 22 No Both legs No No No No No NN
Paper number Hydrops Polihydra mnios Prenatal invasive diagnosis Karyotype Familiarity G.A. at birth Pregnancy outcome Weight at birth Associated anomalies Neonatal outcome Cause of death Treatment
1 No Yes No No No 39 CS 3200 No Normal at 6 months NN
2 No No No No No 40 SD 2600 Fgr Normal at 4 year Scleroth‐erapy
No No No No No TOP No
No No No No No TOP No
Yes Yes No No No 33 IUD 2400 No
3 No Yes Yes 46,XY No 37 CS 2840 No Death in 10 days of life Kasabach‐Merrit syndrome
Yes No No 46,XX No 35 SD 3340 No Death in 15 days of life Cardiomegaly, thrombocitopenia
4 No No Yes 46,xy No TOP No
5 No No Yes 46,XX No TOP No
6 Yes Yes No No No 28 CS 1954 No Death in first day Kasabach‐Merrit syndrome
7 No No Yes LOH for 1q21.2 q44 No TOP Umbilical cord hemangioma and cyst
8 No No No No No TOP No
No Yes No No No TOP No
9 No No Yes NORMAL No TOP No
10 No No Yes 46,XY No 36 SD 3268 No Normal at 2 months NN
11 No No Yes NORMAL Yes TOP No
12 No Yes No No No 37 CS 3210 No Normal at 9 months NN
13 No No Yes 46,XX No 26 PS Umbilical cord hemangioma Death in first day NRDS
14 No Yes Yes 46,XX No 33 CS 3110 Macrosomia, cardiomegalia, Hepatomegaly, cisterna magna obliteration, mild ventriculomegaly Death in first day
15 No No No No No 39 CS 4000 No Normal at 3 years NN
16 No No Yes NORMAL No 38 SD 3200 Bowel obstruction Normal at 13 months NN
17 No No Yes 46,xy No 39 CS Right foot syndactily, hypertrofy left hallux Normal at 7 months NN
18 No Yes Yes NORMAL No 37 SD 2470 Normal at 10 mesi Spontaneous resolution
19 No Yes Yes 46,XY No TOP No
20 No Yes No No No TOP Right diaphragmatic hernia, cystic hygroma
No No No No No 39 SD 3750 Abnormal placement of toes Death in 2 day Kasabach‐Merrit syndrome
No No No No No TOP No
No No No No No TOP Ectrodactily right hand, hyoerechogenic bowel, ascites
21 No No Yes NORMAL No TOP Cataracts of both eyes
22 No No No No 40 SD 3078 No Alive at 4 months NN
23 No No No No No TOP Absence of right foot
24 Yes Yes Yes NORMAL No 37 CS 3690 No Normal at six months NN
25 No No Yes NORMAL No TOP No
26 No Yes Yes 46,XX No 33 SD 4200 Hypertrophy of right femur Death in 4 day Heart failure
27 No Yes Yes NORMAL No 35 SC Bilateral syndactily Death at 5 months
28 No No Yes NORMAL No 0 TOP Hydrocephaly
29 No No No No No 32 CS 2740 Criptorchidism Died after 8 h
30 No No No No No TOP No
31 no no no no yes 34 CS 3177 Hepatomegaly Amputation right leg Embolization, cardioovascular decompression, amputation right hip
32 No No No No No 37 CS 3385 No Excision thoracic lesion
33 No No Yes 46, XY No 0 TOP No
34 No No No No No NN SD No NN
35 No No No No No 0 TOP
36 No Yes No No No NN SD NN Talipes equino‐varus,abductiont of the thumb and sindactil‐y right hand

FIGURE 1.

FIGURE 1

PRISMA 2020 flow diagram for new systematic reviews which included searches of databases and registers only (n. 99 Embase; n. 44 Pubmed; n. 33 Web of Science).

General characteristics including family history, gestational age at diagnosis, familiarity, hemihypertrophy side, extension of the lesion (involvement of trunk, upper arms, and neck), the involvement of internal organs, presence of cardiac failure with hydrops and/or polyhydramnios, presence of associated anomalies, fetal karyotype, fetal and neonatal outcomes, treatment have been summarized in Table 1. The median maternal age was 28 years old and the median gestational age at diagnosis was 22 weeks. We found only one case with positive familiar history, where the mother was affected.

According to prenatal cases described in the literature, the lesion first involves the legs, predominantly the right side (n = 18) (40%), while the left side is the primary origin in 36% (n = 16).

In only three cases (6.8%), there was a primary lesion of other parts of the fetal body, not including the lower limbs (isolated involvement of left foot and upper limbs with thorax).

In 13 cases (29.5%), the lesion did not extend outside the leg. When the lesion extends outside the leg, it generally involves the trunk, and it can reach the upper arms. We found 11 cases of involvement of upper arms (25%). In 4 cases (9%), there were cystic lesions of the neck.

Internal organs were rarely involved: in fact, only in seven cases (15.9%), suspected hemangioma of the lungs, bowel, kidneys, and liver has been reported. In two cases, there was an association with umbilical cord hemangioma. Associated anomalies were found in 17 of 44 cases (38.6%); the most frequent were limb anomalies (7/17, 41% of cases), including ectrodactyly, femur hypertrophy, syndactyly, foot agenesia, and talipes equinovarus.

Fetal traditional karyotype was performed in 20 cases (45.4% of cases), and in only one case, a mutation was found with loss of heterozygosity (LOH) for 1q21.2 q44.

In four cases (9%), the fetus developed hydrops, which seemed not related to the extension of the lesion: in only one case of hydropic fetus, the lesion extended from the lower limb toward the thorax. Among the cases of fetal hydrops, one case had a stillbirth at 33 weeks; one had spontaneous vaginal delivery at 35 weeks, with neonatal death after 15 days for cardiac failure and thrombocytopenia; one case underwent urgent cesarean section at 28 weeks, and the neonate died in the first day of life because of Kasabach‐Merrit syndrome; in the fourth case, cesarean section was performed at 37 weeks for anasarca, and the neonatal outcome was regular at 6 months of life. Polyhydramnios developed in 31.8% of cases (14/44).

In 20 of 44 cases (47.7%), the couple opted for termination of pregnancy (TOP). In the remaining 24 cases, in which the couple was committed to the pregnancy, the median gestational age at birth was 36 weeks (range 28–40), with one intrauterine death at 33 weeks' gestation. The neonatal outcome was reported in 20 of 23 cases. Nine babies (37%) died in the first 5 months of life: four cases due to Kasabach‐Merrit syndrome, one case for heart failure, one case for respiratory distress, and in three cases, the cause of death is unknown.

In 11 of 24 newborns (45%), the outcome was good. In one case, spontaneous resolution of the hemangioma of the left leg and trunk is reported; in one case, sclerotherapy treatment of the lesion was performed and one case had amputation of the leg. In the other eight cases, the need for treatment is not reported, but the outcome reported is good.

4. Discussion

Prenatal diagnosis of KTW can be challenging, due to rarity of the pathology and its overlapping with other genetic syndromes. There is currently no such large collection of prenatal diagnosed cases of KTW in the literature. Our aim was to collect all case reports of prenatal diagnosis of KTW, confirmed after birth, to recognize common ultrasound signs and help clinicians with this complex prenatal diagnosis.

The KTW syndrome is a rare and congenital disease, with an incidence estimated at two to five per 100 000 [1].

This syndrome has a sporadic incidence without any racial or sex predilection, [2] and it is characterized by typical features: port wine stains/capillary hemangiomas due to abnormal ectasis capillaries in the papillary dermis (presenting as red or purple marks that are irregular but may have a comparatively linear border) (98%), venous malformation or varicosities (72%), and limb hypertrophy (67%) [3].

It belongs to a spectrum of limb overgrowth syndromes (PROS), with whose members it shares many similarities.

Differential diagnosis includes Proteus syndrome, which is a genetic mosaic overgrowth disorder characterized by progressive and segmental overgrowth of any affected body tissue. The syndrome is caused by a postzygotic, mosaic‐activating mutation in AKT1 [40], and in rare prenatal cases, it presents a focal overgrowth, without hemihypertrophy, but associated with skeletal and central nervous system anomalies. An exome sequencing can detect mosaic mutation of AKT1 gene [41].

Parkes‐Weber syndrome (PWS) is characterized by the same triad of malformations of KTS combined with arteriovenous fistula [42].

Postnatal KTS diagnosis is easy, and it generally depends on two of the following features of the classical triad of KTS. According to Oduber et al, [43] KTS diagnosis can be clinically diagnosed in postnatal life considering two groups of (symptoms: A) congenital vascular anomalies: capillary (port wine stains), venous (hypoplasia/aplasia of veins, persistent embryonic veins), and lymphatic and B. changing limb sizes (hypertrophy or hypotrophy). If at least one of the group A and one of the group B are present, diagnosis can be made.

In postnatal series, the lower limb is the site of malformations in approximately 95% of patients; lymphatic and venous malformations lead to an overgrowth of the affected limb, with hypertrophy. Enlargement of the extremity consists of bone elongation, circumferential soft‐tissue hypertrophy, or both [44].

Between varicosities, the pathognomonic sign is the persistence of lateral (embryonic) vein, which can be seen in 56% of patients affected [3]. Embryonic veins are easily recognized in postnatal life with MRI and venous doppler.

Bilateral and truncal involvement are rare [45]. Viscera can be affected, with genitourinary involvement in 30% of cases and gastrointestinal in 20% [46, 47]; other visceral vascular malformations can be seen in the liver, retroperitoneum, and pericardium, leading to hemorrhagic complications of the organs involved [45].

Craniofacial and brain anomalies can rarely occur [26, 48].

KTW syndrome can be associated with limb anomalies in about 29% of cases [2].

Redondo et al. described 51 patients with KTS, 17 of which had abnormalities of the hand and/or foot [49].

If large enough, the cutaneous lesions may sequester platelets, possibly leading to Kasabach‐Merritt syndrome, a type of consumptive coagulopathy [50].

The KTW has a sporadic occurrence, with mosaic distribution. It is mostly a sporadic disease with no distinct family history, and it arises from noninherited gene mutations, which are not germline, but somatic mutations [51]. This can be related to the model of autosomal dominant inheritance with incomplete penetrance [52]. Some cases of familiarity with venous malformations led Tian et al. to conduct a genetic analysis to recognize mutations related to KTW. They have demonstrated the involvement of a defect of an angiogenic factor, the VG5Q. The first mutation was a translocation t (5;11), which promotes the VG5Q transcription; the second was mutation E133K, which is a functional mutation that substantially enhances the angiogenic effect of VG5Q, the latter promoting the endothelial proliferation. This factor was found in 5 of 130 affected patients, but never in 200 controls [52].

Wang et al. found one case of KTW syndrome associated with translocation involving chromosomes 8q22.3 and 14q13 [52]. Puiu et al. [53] found a terminal deletion 2q37.3, associated with mental delay.

Prenatal diagnosis of KTW syndrome can be challenging, because ultrasound scans cannot recognize most of the typical anomalies. The hallmarks of the prenatal diagnosis of KTW are cutaneous or subcutaneous cystic areas and limb hypertrophy. Other features may be seen prenatally, such as complex soft‐tissue masses that affect unusual areas (e.g., head, neck, or trunk), nonimmune hydrops fetalis, cardiomegaly, and polyhydramnios [26, 27, 54]. Frequently, it presents in the second trimester, mostly unilateral (72%). When localized in the sacral region, the anomaly can be easily confused with a teratoma [26].

Less than 50 cases of prenatal diagnosis of KTW are described in the literature. While the syndrome can be easily diagnosed in the postnatal life with clinical criteria, skin manifestation (such as port wine stain) cannot be seen in prenatal life. Thus, lateral embryonic vein persistence, which is considered pathognomonic of the syndrome, cannot be diagnosed with fetal ultrasound.

According to prenatal series, our review confirmed the most typical ultrasound future, which is the soft‐tissue lesion (generally involving one leg, most frequently the right side), corresponding to hemangioma and/or lymphatic lesion, leading to isolated limb hypertrophy, with either no flow in case of lymphatic malformation or very low‐velocity blood flow in case of capillary and venous malformation. According to our review, in almost all cases (83%), a hemihypertrophy is found, with one leg site of anechoic and/or mixed lesion. Rarely, the lesion can extend toward the thorax and involve upper limbs and the neck.

In this case, an accurate ultrasound examination of the fetus is necessary to exclude associated anomalies. In fact, while the involvement of internal organs by the lymphovascular lesions was found in 15% of cases, in about 37% of cases, there is an association with other anomalies, first of all, limb anomalies.

Hydrops are not frequent but lead to a bad prognosis. Anyway, prenatal complications, such as hydrops, polyhydramnios, cardiac failure and anemia can appear later in pregnancy, which is why ultrasound follow‐up is necessary.

Although a specific genetic mutation has not been found, genetic counseling and prenatal invasive testing diagnosis should be offered to the couple. More studies are necessary to relate KTW syndrome to a specific mutation related to vascular growth factors, but prenatal diagnosis can be useful for differential diagnosis with Proteus syndrome.

The mortality rate is high (37%) and is mostly related to Kasabach‐Merritt syndrome development. Of the newborns survived, and in most cases, the need for treatment is not reported.

5. Conclusions

Prenatal manifestations of KTW are variable, but in the presence of cystic lesions of the legs, eventually extending toward the trunk or upper limbs, or involving internal organs, with no clear origin, this syndrome must be considered in differential diagnosis. Moreover, the association with limb anomalies, efforts the KTW suspicion.

Prenatal and genetic counseling is necessary to guide the couple in the decision whether to continue or not the pregnancy and, in the latter case, to program birth in a second‐ or third‐level center, and postnatal clinical and/or surgical follow‐up.

Ethics Statement

The authors have nothing to report.

Conflicts of Interest

The authors declare no conflicts of interest.

[Correction added on 13 December 2024, after first online publication: The order of author first names and surnames been been corrected in this version.]

Data Availability Statement

The data that support the findings of this study are available from the corresponding author uponreasonable request.

References

  • 1. Lee A., Driscoll D., Gloviczki P., Clay R., Shaughnessy W., and Stans A., “Evaluation and Management of Pain in Patients With Klippel‐Trenaunay Syndrome: A Review,” Pediatrics 115 (2005): 744–749. [DOI] [PubMed] [Google Scholar]
  • 2. Gloviczki P. and Driscoll D. J., “Klippel‐Trenaunay syndrome: current management,” Phlebology 22 (2007): 291–298. [DOI] [PubMed] [Google Scholar]
  • 3. Jacob A. G., Driscoll D. J., Shaughnessy W. J., Stanson A. W., Clay R. P., and Gloviczki P., “Klippel‐Trénaunay syndrome: spectrum and management,” Mayo Clinic Proceedings 73, no. 1 (1998): 28–36. [DOI] [PubMed] [Google Scholar]
  • 4. Assimakopoulos E., Zafrakas M., Athanasiades A., Peristeri V., Tampakoudis P., and Bontis J., “Klippel‐Trenaunay‐Weber Syndrome With Abdominal Hemangiomata Appearing on Ultrasound Examination as Intestinal Obstruction,” Ultrasound in Obstetrics & Gynecology 22, no. 5 (2003): 549–550. [DOI] [PubMed] [Google Scholar]
  • 5. Gică N., Dumitru A., Panaitescu A. M., et al., “Prenatal Ultrasound Diagnosis of Klippel‐Trenaunay Syndrome,” Diagnostics (Basel) 13, no. 22 (2023): 3400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Singh N., Mandelia A., Nigam N., Yadav S., and Pradhan M., “Fetal Klippel‐Trenaunay‐Weber Syndrome: Antenatal Diagnosis and Postnatal Management,” Journal of Indian Association of Pediatric Surgeons 28, no. 5 (2023): 387–391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Peng H. H., Wang T. H., Chao A. S., Chang Y. L., Shieh S. C., and Chang S. D., “Klippel‐Trenaunay‐Weber Syndrome Involving Fetal Thigh: Prenatal Presentations and Outcomes,” Prenatal Diagnosis 26, no. 9 (2006): 825–830. [DOI] [PubMed] [Google Scholar]
  • 8. Cakiroglu Y., Doğer E., Yildirim Kopuk S., Dogan Y., Calıskan E., and Yucesoy G., “Sonographic Identification of Klippel‐Trenaunay‐Weber Syndrome,” Case Reports in Obstetrics and Gynecology 2013 (2013): 595476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Pang H. Q. and Gao Q. Q., “Prenatal Ultrasonographic Findings in Klippel‐Trenaunay Syndrome: A Case Report,” World Journal of Clinical Cases 9, no. 35 (2021): 10994–10998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Tanaka K., Miyazaki N., Matsushima M., et al., “Prenatal Diagnosis of Klippel‐Trenaunay‐Weber Syndrome With Kasabach‐Merritt Syndrome In Utero,” Journal of Medical Ultrasonics 42, no. 1 (2001): 109–112. [DOI] [PubMed] [Google Scholar]
  • 11. Yu D., Sun L., and Chen T., “Prenatal Ultrasound Diagnosis of Klippel‐Trenaunay‐Weber Syndrome Associated With Umbilical Cord Hemangioma,” Journal of Clinical Ultrasound 49, no. 3 (2021): 254–256. [DOI] [PubMed] [Google Scholar]
  • 12. Paladini D., Lamberti A., Teodoro A., et al., “Prenatal Diagnosis and Hemodynamic Evaluation of Klippel‐Trenaunay‐Weber Syndrome,” Ultrasound in Obstetrics & Gynecology 12, no. 3 (1998): 215–217. [DOI] [PubMed] [Google Scholar]
  • 13. Heydanus R., Wladimiroff J. W., Brandenburg H., Gaillard J. L., Stewart P. A., and Niermeijer M. F., “Prenatal Diagnosis of Klippel‐Trenaunay‐Weber Syndrome: A Case Report,” Ultrasound in Obstetrics & Gynecology 2, no. 5 (1992): 360–363. [DOI] [PubMed] [Google Scholar]
  • 14. Chen C. P., Lin S. P., Chang T. Y., et al., “Prenatal Sonographic Findings of Klippel‐Trénaunay‐Weber Syndrome,” Journal of Clinical Ultrasound 35, no. 7 (2007): 409–412. [DOI] [PubMed] [Google Scholar]
  • 15. Gonçalves L. F., Rojas M. V., Vitorello D., Pereira E. T., Pereima M., and Neto J. A. S., “Prenatal Diagnosis of the Klippel‐Trenaunay‐Weber Syndrome,” Prenatal Diagnosis 14, no. 10 (1994): 989–992. [DOI] [PubMed] [Google Scholar]
  • 16. Gonçalves L. F., Rojas M. V., Vitorello D., Pereira E. T., Pereima M., and Saab Neto J. A., “Klippel‐Trenaunay‐Weber Syndrome Presenting as Massive Lymphangiohemangioma of the Thigh: Prenatal Diagnosis,” Ultrasound in Obstetrics & Gynecology 15, no. 6 (2000): 537–541. [DOI] [PubMed] [Google Scholar]
  • 17. Sahinoglu Z., Uludogan M., and Delikara N. M., “Prenatal Sonographic Diagnosis of Klippel‐Trenaunay‐Weber Syndrome Associated With Umbilical Cord Hemangioma,” American Journal of Perinatology 20, no. 1 (2003): 1–6. [DOI] [PubMed] [Google Scholar]
  • 18. Drose J. A., Thickman D., Wiggins J., and Haverkamp A. B., “Fetal Echocardiographic Findings in the Klippel‐Trenaunay‐Weber Syndrome,” Journal of Ultrasound in Medicine 10, no. 9 (1991): 525–527. [DOI] [PubMed] [Google Scholar]
  • 19. Warhit J. M., Goldman M. A., Sachs L., Weiss L. M., and Pek H., “Klippel‐Trenaunay‐Weber Syndrome: Appearance In Utero,” Journal of Ultrasound in Medicine 2, no. 11 (1983): 515–518. [DOI] [PubMed] [Google Scholar]
  • 20. Coombs P. R., James P. A., and Edwards A. G., “Sonographic Identification of Lower Limb Venous Hypoplasia in the Prenatal Diagnosis of Klippel‐Trénaunay Syndrome,” Ultrasound in Obstetrics & Gynecology 34, no. 6 (2009): 727–729. [DOI] [PubMed] [Google Scholar]
  • 21. Hatjis C. G., Philip A. G., Anderson G. G., and Mann L. I., “The In Utero Ultrasonographic Appearance of Klippel‐Trenaunay‐Weber Syndrome,” American Journal of Obstetrics and Gynecology 139, no. 8 (1981): 972–974. [DOI] [PubMed] [Google Scholar]
  • 22. Hayashi M., Kurishita M., Sodemodo T., Kozu H., Kumasaka T., and Saiki S., “Prenatal Ultrasonic Appearance of the Klippel‐Trenaunay‐Weber Syndrome Mimicking Sacrococcygeal Teratoma With an Elevated Level of Maternal Serum hCG,” Prenatal Diagnosis 13, no. 12 (1993): 1162–1163. [DOI] [PubMed] [Google Scholar]
  • 23. Ivanitskaya O., Andreeva E., and Odegova N., “Prenatal Diagnosis of Klippel‐Trenaunay Syndrome: Series of Four Cases and Review of the Literature,” Ultrasound 28, no. 2 (2020): 91–102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Lewis B. D., Doubilet P. M., Heller V. L., Bierre A., and Bieber F. R., “Cutaneous and Visceral Hemangiomata in the Klippel‐Trenaunay‐Weber Syndrome: Antenatal Sonographic Detection,” AJR. American Journal of Roentgenology 147, no. 3 (1986): 598–600. [DOI] [PubMed] [Google Scholar]
  • 25. Meholic A. J., Freimanis A. K., Stucka J., and LoPiccolo M. L., “Sonographic In Utero Diagnosis of Klippel‐Trenaunay‐Weber Syndrome,” Journal of Ultrasound in Medicine 10, no. 2 (1991): 111–114. [DOI] [PubMed] [Google Scholar]
  • 26. Meizner I., Rosenak D., Nadjari M., and Maor E., “Sonographic Diagnosis of Klippel‐Trenaunay‐Weber Syndrome Presenting as a Sacrococcygeal Mass at 14 to 15 weeks' Gestation,” Journal of Ultrasound in Medicine 13, no. 11 (1994): 901–904. [DOI] [PubMed] [Google Scholar]
  • 27. Mor Z., Schreyer P., Wainraub Z., Hayman E., and Caspi E., “Nonimmune Hydrops Fetalis Associated With Angioosteohypertrophy (Klippel‐Trenaunay) Syndrome,” American Journal of Obstetrics and Gynecology 159, no. 5 (1988): 1185–1186. [DOI] [PubMed] [Google Scholar]
  • 28. Seoud M., Santos‐Ramos R., and Friedman J. M., “Early Prenatal Ultrasonic Findings in Klippel‐Trenaunay‐Weber Syndrome,” Prenatal Diagnosis 4, no. 3 (1984): 227–230. [DOI] [PubMed] [Google Scholar]
  • 29. Shalev E., Romano S., Nseir T., and Zuckerman H., “Klippel‐Trenaunay syndrome: ultrasonic prenatal diagnosis,” Journal of Clinical Ultrasound 16, no. 4 (1988): 268–270. [DOI] [PubMed] [Google Scholar]
  • 30. Yancey M. K., Lasley D., and Richards D. S., “An Unusual Neck Mass in a Fetus With Klippel‐Trenaunay‐Weber Syndrome,” Journal of Ultrasound in Medicine 12, no. 12 (1993): 779–782. [DOI] [PubMed] [Google Scholar]
  • 31. Yankowitz J., Slagel D. D., and Williamson R., “Prenatal Diagnosis of Klippel‐Trénaunay‐Weber Syndrome by Ultrasound,” Prenatal Diagnosis 14, no. 8 (1994): 745–749. [DOI] [PubMed] [Google Scholar]
  • 32. Zoppi M. A., Ibba R. M., Floris M., Putzolu M., Crisponi G., and Monni G., “Prenatal Sonographic Diagnosis of Klippel‐Trénaunay‐Weber Syndrome With Cardiac Failure,” Journal of Clinical Ultrasound 29, no. 7 (2001): 422–426. [DOI] [PubMed] [Google Scholar]
  • 33. Shih J. C., Shyu M. K., Chang C. Y., et al., “Application of the Surface Rendering Technique of Three‐Dimensional Ultrasound in Prenatal Diagnosis and Counselling of Klippel‐Trenaunay‐Weber Syndrome,” Prenatal Diagnosis 18, no. 3 (1998): 298–302. [DOI] [PubMed] [Google Scholar]
  • 34. Christenson L., Yankowitz J., and Robinson R., “Prenatal Diagnosis of Klippel‐Trénaunay‐Weber Syndrome as a Cause for In Utero Heart Failure and Severe Postnatal Sequelae,” Prenatal Diagnosis 17, no. 12 (1997): 1176–1180. [PubMed] [Google Scholar]
  • 35. Roberts R. V., Dickinson J. E., Hugo P. J., and Barker A., “Prenatal Sonographic Appearances of Klippel‐Trenaunay‐Weber Syndrome,” Prenatal Diagnosis 19, no. 4 (1999): 369–371. [PubMed] [Google Scholar]
  • 36. Martin W. L., Ismail K. M., Brace V., McPherson L., Chapman S., and Kilby M. D., “Klippel‐Trenaunay‐Weber (KTW) Syndrome: The Use of In Utero Magnetic Resonance Imaging (MRI) in a Prospective Diagnosis,” Prenatal Diagnosis 21, no. 4 (2001): 311–313. [DOI] [PubMed] [Google Scholar]
  • 37. Mejia C. A. E., Ramirez J., Medina O., et al., “Klippel–Trenaunay–Weber syndrome,” 2000, https://sono‐world.com/TheFetus/page.aspx?id1/4423.
  • 38. Volkov A., Matsionis A., Voloshin V., et al., “Klippel–Trenaunay–Weber Syndrome,” 2009, https://sono‐world.com/TheFetus/page.aspx?id/2639.
  • 39. Al‐Asali O., Abo‐Almaged I., Al Taher A., et al., “Klippel–Trenaunay–Weber Syndrome Case of the Week #286,” https://sonoworld.com/TheFetus/case.aspx?id1/42861.
  • 40. Abell K., Tolusso L., Smith N., et al., “Prenatal Diagnosis of Proteus Syndrome: Diagnosis of an AKT1 Mutation From Amniocytes,” Birth Defects Research 112, no. 19 (2020): 1733–1737, 10.1002/bdr2.1801. Epub 2020 Sep 15. [DOI] [PubMed] [Google Scholar]
  • 41. International Society for the Study of Vascular Anomalies© , Classification of Vascular Anomalies (Milwaukee, WI, US: ISSVA, 2014). [Google Scholar]
  • 42. Güngor Gündoğan T., “Jacquemyn Y Klippel‐Trenaunay Syndrome and Pregnancy,” Obstetrics and Gynecology International 2010 (2010): 706850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Oduber C. E., Van Der Horst C. M., and Hennekam R. C., “Klippel–Trenaunay Syndrome: Diagnostic Criteria and Hypothesis on Eti‐Ology,” Annals of Plastic Surgery 60 (2008): 217–223. [DOI] [PubMed] [Google Scholar]
  • 44. Timur A. A., Driscoll D. J., and Wang Q., “Biomedicine and Diseases: The Klippel‐Trenaunay Syndrome, Vascular Anomalies and Vascular Morphogenesis,” Cellular and Molecular Life Sciences 62, no. 13 (2005): 1434–1447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Cha S. H., Romeo M. A., and Neutze J. A., “Visceral Manifestations of Klippel‐Trénaunay Syndrome,” Radiographics 25, no. 6 (2005): 1694–1697, 10.1148/rg.256055042. [DOI] [PubMed] [Google Scholar]
  • 46. Wilson C. L., Song L. M., Chua H., et al., “Bleeding From Cavernous Angiomatosis of the Rectum in Klippel‐Tre'naunay Syndrome: Report of Three Cases and Literature Review,” American Journal of Gastroenterology 96 (2001): 2783–2788. [DOI] [PubMed] [Google Scholar]
  • 47. Husmann D. A., Rathburn S. R., and Driscoll D. J., “Klippel‐Trenaunay Syndrome: Incidence and Treatment of Genitourinary Sequelae,” Journal of Urology 177, no. 4 (2007): 1244–1249. [DOI] [PubMed] [Google Scholar]
  • 48. Anlar B. and Erzen C., “Yalaz K Klippel‐Trenaunay‐Weber Syndrome: A Case With Cerebral and Cerebellar Hemihypertrophy,” Neuroradiology 30 (1988): 360. [DOI] [PubMed] [Google Scholar]
  • 49. Redondo P., Aguado L., and Martinez‐Cuesta A., “Diagnosis and Management of Extensive Vascular Malformations of the Lower Limb. Part I. Clinical Diagnosis,” Journal of the American Academy of Dermatology 65 (2011): 893–906. [DOI] [PubMed] [Google Scholar]
  • 50. Happel R., “Klippel‐Trénaunay syndrome: is it a paradominant trait?,” British Journal of Dermatology 1228 (1993): 465–466. [DOI] [PubMed] [Google Scholar]
  • 51. Tian X. L., Kadaba R., You S. A., et al., “Identification of an Angiogenic Factor That When Mutated Causes Susceptibility to Klippel‐Trenaunay Syndrome,” Nature 427, no. 6975 (2004): 640–645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Wang Q., Timur A. A., Szafranski P., et al., “Identification and Molecular Characterization of de Novo Translocation t (8;14) (q22.3;q13) Associated With a Vascular and Tissue Overgrowth Syndrome,” Cytogenetics and Cell Genetics 95, no. 3–4 (2001): 183–188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Puiu I., Stoica A., Sosoi S., Puiu A., Ioana M., and Burada F., “Terminal Deletion 2q37.3 in a Patient With Klippel‐Trenaunay‐Weber Syndrome,” Fetal and Pediatric Pathology 32 (2013): 351–356. [DOI] [PubMed] [Google Scholar]
  • 54. Drose J. A., Thickman D., and Wiggins J., “Fetal Echocardiographic Findings in the Klippel‐Trenaunay‐Weber Syndrome,” Journal of Ultrasound in Medicine 10, no. 9 (1991): 525–527. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author uponreasonable request.


Articles from Journal of Clinical Ultrasound are provided here courtesy of Wiley

RESOURCES